Company Filing History:
2 out of 200 
2 out of 180 
Years Active: 2008-2013
Title: Innovator Spotlight: Myoung-Soon Park from Gyeonggi-do, KR
Introduction: Myoung-Soon Park is a distinguished inventor hailing from Gyeonggi-do, South Korea. With a passion for research and development, Park has contributed significantly to the fields of medicinal chemistry and pharmacology through his innovative inventions.
Latest Patents: Myoung-Soon Park holds two notable patents that focus on 2-pyridyl substituted imidazoles, which serve as ALK5 and/or ALK4 inhibitors. The first patent involves a compound designed to treat renal, liver, or pulmonary fibrosis, utilizing a defined chemical structure to achieve therapeutic effects. The second patent similarly encompasses compounds that inhibit the TGF-β and/or activin signaling pathway in mammals, showcasing the versatility and potential impact of these innovations in medical treatments.
Career Highlights: Over the course of his career, Myoung-Soon Park has worked for reputable organizations, including SK Chemicals Co., Ltd. and the Ewha University-Industry Collaboration Foundation. His professional journey highlights his commitment to advancing biomedical research and developing novel therapeutic strategies.
Collaborations: In his innovative endeavors, Park has collaborated with esteemed colleagues, including Dae-Kee Kim and Yung-Jue Bang. These partnerships have further enhanced his research capabilities and have contributed to the successful development of his patented inventions.
Conclusion: Myoung-Soon Park’s contributions to the field of medicinal chemistry are significant, demonstrating the importance of innovative thinking in the pursuit of new medical therapies. His patents exemplify the intersection of research and practical application, aiming to address critical health concerns through scientific ingenuity.